Johnson & Johnson
NYSE:JNJ

Watchlist Manager
Johnson & Johnson Logo
Johnson & Johnson
NYSE:JNJ
Watchlist
Price: 158.39 USD -0.93% Market Closed
Updated: Aug 14, 2024
Have any thoughts about
Johnson & Johnson?
Write Note

Intrinsic Value

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. [ Read More ]

The intrinsic value of one JNJ stock under the Base Case scenario is hidden USD. Compared to the current market price of 158.39 USD, Johnson & Johnson is hidden .

Key Points:
JNJ Intrinsic Value
HIDDEN
Unlock
Worst Case
Base Case
Best Case

Valuation Backtest
Johnson & Johnson

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling JNJ based on its intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

AI Assistant
AI Assistant
Ask me anything about Johnson & Johnson

Provide an overview of the primary business activities
of Johnson & Johnson.

What unique competitive advantages
does Johnson & Johnson hold over its rivals?

What risks and challenges
does Johnson & Johnson face in the near future?

Has there been any significant insider trading activity
in Johnson & Johnson recently?

Summarize the latest earnings call
of Johnson & Johnson.

What significant events have occurred
in Johnson & Johnson over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Johnson & Johnson.

Provide P/S
for Johnson & Johnson.

Provide P/E
for Johnson & Johnson.

Provide P/OCF
for Johnson & Johnson.

Provide P/FCFE
for Johnson & Johnson.

Provide P/B
for Johnson & Johnson.

Provide EV/S
for Johnson & Johnson.

Provide EV/GP
for Johnson & Johnson.

Provide EV/EBITDA
for Johnson & Johnson.

Provide EV/EBIT
for Johnson & Johnson.

Provide EV/OCF
for Johnson & Johnson.

Provide EV/FCFF
for Johnson & Johnson.

Provide EV/IC
for Johnson & Johnson.

Show me price targets
for Johnson & Johnson made by professional analysts.

What are the Revenue projections
for Johnson & Johnson?

How accurate were the past Revenue estimates
for Johnson & Johnson?

What are the Net Income projections
for Johnson & Johnson?

How accurate were the past Net Income estimates
for Johnson & Johnson?

What are the EPS projections
for Johnson & Johnson?

How accurate were the past EPS estimates
for Johnson & Johnson?

What are the EBIT projections
for Johnson & Johnson?

How accurate were the past EBIT estimates
for Johnson & Johnson?

Compare the revenue forecasts
for Johnson & Johnson with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Johnson & Johnson and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Johnson & Johnson against its competitors.

Analyze the profit margins
(gross, operating, and net) of Johnson & Johnson compared to its peers.

Compare the P/E ratios
of Johnson & Johnson against its peers.

Discuss the investment returns and shareholder value creation
comparing Johnson & Johnson with its peers.

Analyze the financial leverage
of Johnson & Johnson compared to its main competitors.

Show all profitability ratios
for Johnson & Johnson.

Provide ROE
for Johnson & Johnson.

Provide ROA
for Johnson & Johnson.

Provide ROIC
for Johnson & Johnson.

Provide ROCE
for Johnson & Johnson.

Provide Gross Margin
for Johnson & Johnson.

Provide Operating Margin
for Johnson & Johnson.

Provide Net Margin
for Johnson & Johnson.

Provide FCF Margin
for Johnson & Johnson.

Show all solvency ratios
for Johnson & Johnson.

Provide D/E Ratio
for Johnson & Johnson.

Provide D/A Ratio
for Johnson & Johnson.

Provide Interest Coverage Ratio
for Johnson & Johnson.

Provide Altman Z-Score Ratio
for Johnson & Johnson.

Provide Quick Ratio
for Johnson & Johnson.

Provide Current Ratio
for Johnson & Johnson.

Provide Cash Ratio
for Johnson & Johnson.

What is the historical Revenue growth
over the last 5 years for Johnson & Johnson?

What is the historical Net Income growth
over the last 5 years for Johnson & Johnson?

What is the current Free Cash Flow
of Johnson & Johnson?

Discuss the annual earnings per share (EPS)
trend over the past five years for Johnson & Johnson.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Johnson & Johnson

Current Assets 57.8B
Cash & Short-Term Investments 25.5B
Receivables 15.8B
Other Current Assets 16.5B
Non-Current Assets 123.3B
Long-Term Investments 470m
PP&E 19.7B
Intangibles 84B
Other Non-Current Assets 19.1B
Current Liabilities 53.9B
Accounts Payable 8.8B
Accrued Liabilities 30.9B
Short-Term Debt 8.5B
Other Current Liabilities 5.7B
Non-Current Liabilities 55.6B
Long-Term Debt 31.6B
Other Non-Current Liabilities 24B
Efficiency

Earnings Waterfall
Johnson & Johnson

Revenue
86.6B USD
Cost of Revenue
-26.5B USD
Gross Profit
60.1B USD
Operating Expenses
-35.2B USD
Operating Income
24.9B USD
Other Expenses
13.1B USD
Net Income
38B USD

Free Cash Flow Analysis
Johnson & Johnson

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Johnson & Johnson's second quarter of 2024 showcased robust performance, driven by strong sales and innovative milestones. Worldwide sales reached $22.4 billion, marking a 6.6% increase, with notable contributions from key products in oncology and immunology. The company's net earnings were $4.7 billion, with adjusted earnings per share up by 10.2% to $2.82. Their Innovative Medicine segment grew by 7.8%, while MedTech sales increased by 4.4%. J&J projects full-year operational sales growth between 6.1% and 6.6%, adjusting EPS guidance to $10-$10.10 per share, reflecting recent strategic acquisitions【4:0†source】.

What is Earnings Call?
Fundamental Scores

JNJ Profitability Score
Profitability Due Diligence

Johnson & Johnson's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Gross Profit
Positive Free Cash Flow
Exceptional ROE
hidden
Profitability
Score

Johnson & Johnson's profitability score is hidden . The higher the profitability score, the more profitable the company is.

JNJ Solvency Score
Solvency Due Diligence

Johnson & Johnson's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Positive Net Debt
hidden
Solvency
Score

Johnson & Johnson's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

JNJ Price Targets Summary
Johnson & Johnson

Wall Street analysts forecast JNJ stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JNJ is 174.9 USD with a low forecast of 151.5 USD and a high forecast of 225.75 USD.

Lowest
Price Target
151.5 USD
4% Downside
Average
Price Target
174.9 USD
10% Upside
Highest
Price Target
225.75 USD
43% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for JNJ?

Click here to dive deeper.

Shareholder Yield

Current shareholder yield for JNJ is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Unlock
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN
Want to learn more about JNJ dividends, buybacks, and debt paydown yield?

Click here to dive deeper.

JNJ Price
Johnson & Johnson

1M 1M
+6%
6M 6M
+2%
1Y 1Y
-9%
3Y 3Y
-6%
5Y 5Y
+35%
10Y 10Y
+98%
Annual Price Range
158.39
52w Low
144.38
52w High
174.01
Price Metrics
Average Annual Return 10.7%
Standard Deviation of Annual Returns 3.09%
Max Drawdown -27%
Shares Statistics
Market Capitalization 381.2B USD
Shares Outstanding 2 407 239 936
Percentage of Shares Shorted 0.75%

Competitive Landscape

Ownership

JNJ Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

JNJ News

Other Videos

Company Profile

Johnson & Johnson Logo
Johnson & Johnson

Country

United States of America

Industry

Pharmaceuticals

Market Cap

381.2B USD

Dividend Yield

3.04%

Description

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. The company is headquartered in New Brunswick, New Jersey and currently employs 141,700 full-time employees. The firm operates through three segments: Consumer Health, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer Health segment includes a range of products that is focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopaedics, surgery, and vision fields. Its geographic area includes the United States, Europe, Western Hemisphere (excluding the United States), and Africa, Asia and Pacific.

Contact

NEW JERSEY
New Brunswick
One Johnson & Johnson Plaza
+17325242455.0
www.jnj.com

IPO

1944-09-25

Employees

141 700

Officers

CEO & Chairman
Mr. Joaquin Duato
Executive VP & CFO
Mr. Joseph J. Wolk CPA
Executive VP & Chief Human Resources Officer
Dr. Peter M. Fasolo Ph.D.
Executive VP & Worldwide Chairman of Innovative Medicine
Ms. Jennifer L. Taubert
Executive Vice President of Innovative Medicine, R&D
Dr. John C. Reed M.D., Ph.D.
Controller & Chief Accounting Officer
Mr. Robert J. Decker Jr.
Show More
Executive VP & Chief Information Officer
Mr. James Swanson
Vice President of Investor Relations
Ms. Jessica Moore
Chief Compliance Officer
Mr. Dirk Brinckman
Executive VP & General Counsel
Ms. Elizabeth Forminard
Show Less

See Also

Discover More
What is the Intrinsic Value of one JNJ stock?

The intrinsic value of one JNJ stock under the Base Case scenario is hidden USD.

Is JNJ stock undervalued or overvalued?

Compared to the current market price of 158.39 USD, Johnson & Johnson is hidden .

Back to Top